JEMPERLI may help your immune system fight cancer

JEMPERLI is not chemotherapy or radiation. It is an immunotherapy (IH-myoo-noh-THAYR-uh-pee), which means it is designed to work with the body’s immune system to find and attack cancer cells.

Understanding immunotherapy

Here’s how JEMPERLI is designed to work with the body to help fight cancer:

Cancer cells can hide from your immune system

Hidden cancer cellsCancer cells can hidefrom your immune system. Cells are then able to grow and spread

JEMPERLI prevents cancer cells from hiding

Exposed cancer cellsJEMPERLI may prevent cancer cells from hidingso your immune system can find and attack them

Could JEMPERLI be right for you?

If you have dMMR* endometrial cancer that has returned or spread outside your uterus (advanced) and after you have received chemotherapy containing platinum and your cancer cannot be treated by surgery or radiation, your doctor may prescribe JEMPERLI.

*dMMR stands for “mismatch repair deficiency.” It is an important biomarker in endometrial cancer that can help your doctor decide if JEMPERLI is appropriate for you.

Light bulb icon

Good to know

Ask your doctor about MMR testing, which can help determine if JEMPERLI may be right for you.

Learn About MMR Testing

Bar graph icon

JEMPERLI study results

Want to learn how JEMPERLI may help?

See Study Results

IV bag icon

How is JEMPERLI given?

When starting any treatment, it’s natural to have questions about what you may expect—like how JEMPERLI is given.

Get the Details

Download icon

Resources for you

Knowledge is power. That's why we're committed to providing you with educational resources to help you stay informed along your treatment journey.

Go to Resources

Related FAQs

  • How has JEMPERLI been studied?

    Researchers have conducted clinical trials to study the effectiveness, risks, and side effects associated with JEMPERLI. Clinical trials are still ongoing to evaluate the effectiveness, risks, and side effects of JEMPERLI.

  • Is advanced or returned endometrial cancer common?

    About 1 in 4 people with endometrial cancer has cancer that has spread outside the uterus (advanced) or has returned.